Literature DB >> 19405094

Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.

Karen Nuytemans1, Bram Meeus, David Crosiers, Nathalie Brouwers, Dirk Goossens, Sebastiaan Engelborghs, Philippe Pals, Barbara Pickut, Marleen Van den Broeck, Ellen Corsmit, Patrick Cras, Peter P De Deyn, Jurgen Del-Favero, Christine Van Broeckhoven, Jessie Theuns.   

Abstract

The relative contribution of simple mutations and copy number variations (CNVs) in SNCA, PARK2, PINK1, PARK7, and LRRK2 to the genetic etiology of Parkinson disease (PD) is still unclear because most studies did not completely analyze each gene. In a large group of Belgian PD patients (N = 310) and control individuals (N = 270), we determined the mutation frequency of both simple mutations and CNVs in these five PD genes, using direct sequencing, multiplex amplicon quantification (MAQ), and real-time PCR assays. Overall, we identified 14 novel heterozygous variants, of which 11 were absent in control individuals. We observed eight PARK2 (multiple) exon multiplications in PD patients and one exon deletion in a control individual. Furthermore, we identified one SNCA whole-gene duplication. The PARK2 and LRRK2 mutation frequencies in Belgian PD patients were similar to those reported in other studies. However, at this stage the true pathogenic nature of some heterozygous mutations in recessive genes remains elusive. Furthermore, though mutations is SNCA, PINK1, and PARK7 are rare, our identification of a SNCA duplication confirmed that screening of these genes remains meaningful. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19405094     DOI: 10.1002/humu.21007

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  26 in total

1.  Parkinson disease: genetic testing in Parkinson disease-who should be assessed?

Authors:  Christine Klein; Ana Djarmati
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

2.  Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Authors:  Owen A Ross; Alexandra I Soto-Ortolaza; Michael G Heckman; Jan O Aasly; Nadine Abahuni; Grazia Annesi; Justin A Bacon; Soraya Bardien; Maria Bozi; Alexis Brice; Laura Brighina; Christine Van Broeckhoven; Jonathan Carr; Marie-Christine Chartier-Harlin; Efthimios Dardiotis; Dennis W Dickson; Nancy N Diehl; Alexis Elbaz; Carlo Ferrarese; Alessandro Ferraris; Brian Fiske; J Mark Gibson; Rachel Gibson; Georgios M Hadjigeorgiou; Nobutaka Hattori; John P A Ioannidis; Barbara Jasinska-Myga; Beom S Jeon; Yun Joong Kim; Christine Klein; Rejko Kruger; Elli Kyratzi; Suzanne Lesage; Chin-Hsien Lin; Timothy Lynch; Demetrius M Maraganore; George D Mellick; Eugénie Mutez; Christer Nilsson; Grzegorz Opala; Sung Sup Park; Andreas Puschmann; Aldo Quattrone; Manu Sharma; Peter A Silburn; Young Ho Sohn; Leonidas Stefanis; Vera Tadic; Jessie Theuns; Hiroyuki Tomiyama; Ryan J Uitti; Enza Maria Valente; Simone van de Loo; Demetrios K Vassilatis; Carles Vilariño-Güell; Linda R White; Karin Wirdefeldt; Zbigniew K Wszolek; Ruey-Meei Wu; Matthew J Farrer
Journal:  Lancet Neurol       Date:  2011-08-30       Impact factor: 44.182

3.  Genetic Paradoxes in an Italian Family with PARK2 Multiexon Duplication.

Authors:  Simona Petrucci; Gina Ferrazzano; Monia Ginevrino; Manuela Tolve; Isabella Berardelli; Alfredo Berardelli; Giovanni Fabbrini; Enza Maria Valente
Journal:  Mov Disord Clin Pract       Date:  2017-09-08

4.  Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe.

Authors:  Justin P Rubio; Simon Topp; Liling Warren; Pamela L St Jean; Daniel Wegmann; Darren Kessner; John Novembre; Judong Shen; Dana Fraser; Jennifer Aponte; Keith Nangle; Lon R Cardon; Margaret G Ehm; Stephanie L Chissoe; John C Whittaker; Matthew R Nelson; Vincent E Mooser
Journal:  Hum Mutat       Date:  2012-04-04       Impact factor: 4.878

5.  Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

Authors:  Karen S Marder; Ming X Tang; Helen Mejia-Santana; Llency Rosado; Elan D Louis; Cynthia L Comella; Amy Colcher; Andrew D Siderowf; Danna Jennings; Martha A Nance; Susan Bressman; William K Scott; Caroline M Tanner; Susan F Mickel; Howard F Andrews; Cheryl Waters; Stanley Fahn; Barbara M Ross; Lucien J Cote; Steven Frucht; Blair Ford; Roy N Alcalay; Michael Rezak; Kevin Novak; Joseph H Friedman; Ronald F Pfeiffer; Laura Marsh; Brad Hiner; Gregory D Neils; Miguel Verbitsky; Sergey Kisselev; Elise Caccappolo; Ruth Ottman; Lorraine N Clark
Journal:  Arch Neurol       Date:  2010-06

6.  Genome-wide analysis of deletions in maize population reveals abundant genetic diversity and functional impact.

Authors:  Xiao Zhang; Yonghui Zhu; Karl A G Kremling; M Cinta Romay; Robert Bukowski; Qi Sun; Shibin Gao; Edward S Buckler; Fei Lu
Journal:  Theor Appl Genet       Date:  2021-10-18       Impact factor: 5.699

7.  High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2.

Authors:  Liyong Wang; Karen Nuytemans; Guney Bademci; Cherylyn Jauregui; Eden R Martin; William K Scott; Jeffery M Vance; Stephan Zuchner
Journal:  Hum Mutat       Date:  2013-05-28       Impact factor: 4.878

Review 8.  Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

Authors:  Erika Guerrero; P Vasudevaraju; Muralidhar L Hegde; G B Britton; K S Rao
Journal:  Mol Neurobiol       Date:  2012-08-26       Impact factor: 5.590

Review 9.  Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Authors:  Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras
Journal:  J Neurol       Date:  2014-05-14       Impact factor: 4.849

10.  Genome wide association studies and prion disease.

Authors:  Ana Lukic; Simon Mead
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.